Edition:
India

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
16 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.40
Open
$0.41
Day's High
$0.41
Day's Low
$0.38
Volume
91,748
Avg. Vol
175,327
52-wk High
$2.60
52-wk Low
$0.36

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates